Page last updated: 2024-09-05

sb 203580 and 2-(4-hydroxyanilino)-1,4-naphthoquinone

sb 203580 has been researched along with 2-(4-hydroxyanilino)-1,4-naphthoquinone in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(2-(4-hydroxyanilino)-1,4-naphthoquinone)
Trials
(2-(4-hydroxyanilino)-1,4-naphthoquinone)
Recent Studies (post-2010) (2-(4-hydroxyanilino)-1,4-naphthoquinone)
3,48941,1371205

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)2-(4-hydroxyanilino)-1,4-naphthoquinone (IC50)
Janus kinase 2 (a protein tyrosine kinase)Homo sapiens (human)7.532
rac GTPase-activating protein 1 isoform aHomo sapiens (human)23.72

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dai, JR; Deretey, E; Foster, JE; Liao, LC; Ng, W; Pasternak, A; Redden, PR; Reid, N; Slon-Usakiewicz, JJ; Toledo-Sherman, L; Uger, MD1

Other Studies

1 other study(ies) available for sb 203580 and 2-(4-hydroxyanilino)-1,4-naphthoquinone

ArticleYear
Frontal affinity chromatography with MS detection of EphB2 tyrosine kinase receptor. 2. Identification of small-molecule inhibitors via coupling with virtual screening.
    Journal of medicinal chemistry, 2005, May-05, Volume: 48, Issue:9

    Topics: Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Chromatography, Affinity; Databases, Factual; Enzyme-Linked Immunosorbent Assay; Heterocyclic Compounds; Humans; Mass Spectrometry; Models, Molecular; Molecular Weight; Naphthoquinones; Phosphorylation; Protein Structure, Tertiary; Quantitative Structure-Activity Relationship; Receptor, EphB2; Sulfides

2005